Breaking News Instant updates and real-time market news.

RMD

ResMed

$97.37

-4.35 (-4.28%)

07:32
04/18/19
04/18
07:32
04/18/19
07:32

ResMed upgraded to Neutral from Underweight at JPMorgan

JPMorgan analyst David Low upgraded ResMed to Neutral from Underweight ahead of the company's fiscal Q3 results.

  • 02

    May

  • 05

    Jun

RMD ResMed
$97.37

-4.35 (-4.28%)

01/25/19
GSCO
01/25/19
DOWNGRADE
GSCO
Neutral
ResMed downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Chris Cooper downgraded ResMed to Neutral and lowered his price target for the shares to A$15.20 from A$16.70. Having been "priced for perfection" going into the Q2 earnings report, the company delivered a "meaningful" 3% sales miss, Cooper tells investors in a post-earnings research note. The analyst sees enough near-term fundamental risk to downgrade the stock.
01/25/19
JPMS
01/25/19
DOWNGRADE
JPMS
Underweight
ResMed downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst David Low downgraded ResMed to Underweight and lowered his price target for the shares to A$13.40 from A$15.50 following the company's fiscal Q2 results. Goldman Sachs this morning also downgraded ResMed.
01/28/19
BMOC
01/28/19
NO CHANGE
Target $120
BMOC
Outperform
ResMed price target lowered to $120 from $124 at BMO Capital
BMO Capital analyst Joanne Wuensch lowered her price target on ResMed to $120 after its lower than expected reported Q2 revenues and a 17% decline in its stock price late last week. The analyst believes that this is the time to step back into the stock however, keeping her Outperform rating while noting that double-digit declines for the shares are rare and should be followed by a recovery. Wuensh is positive on the company's ability to leverage its "respiratory devices to provide cloud-connected medical data and solutions to patients and physicians."
03/20/19
DBAB
03/20/19
UPGRADE
Target $125
DBAB
Buy
ResMed upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded ResMed to Buy from Hold and raised its price target on the stock to $125 from $115.

TODAY'S FREE FLY STORIES

VERU

Veru

$2.47

0.17 (7.39%)

06:33
12/12/19
12/12
06:33
12/12/19
06:33
Earnings
Veru reports Q4 EPS (5c), consensus (5c) »

Reports Q4 revenue $8.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TRKNY

Turk Telekom

$0.00

(0.00%)

06:31
12/12/19
12/12
06:31
12/12/19
06:31
Downgrade
Turk Telekom rating change  »

Turk Telekom downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$0.00

(0.00%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Upgrade
AkzoNobel rating change  »

AkzoNobel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGNX

Cognex

$52.45

1.51 (2.96%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Initiation
Cognex initiated  »

Cognex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

, INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

06:29
12/12/19
12/12
06:29
12/12/19
06:29
Recommendations
Americold Realty Trust, Invitation Homes analyst commentary  »

Citi adds Americold…

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSG

Wanda Sports

$2.82

-0.01 (-0.35%)

06:28
12/12/19
12/12
06:28
12/12/19
06:28
Downgrade
Wanda Sports rating change  »

Wanda Sports downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

, SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Glaukos, SeaSpine, Merit Medical, Medtronic, Teleflex rating change  »

SeaSpine, Glaukos…

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

MMSI

Merit Medical

$29.99

0.69 (2.35%)

MDT

Medtronic

$111.67

0.62 (0.56%)

TFX

Teleflex

$354.93

1.18 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

REG

Regency Centers

$62.65

-1.6 (-2.49%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Regency Centers rating change  »

Regency Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRI

Weingarten Realty

$31.03

-0.41 (-1.30%)

06:26
12/12/19
12/12
06:26
12/12/19
06:26
Upgrade
Weingarten Realty rating change  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLCE

Children's Place

$54.36

-16.31 (-23.08%)

06:25
12/12/19
12/12
06:25
12/12/19
06:25
Downgrade
Children's Place rating change  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$74.56

-1.08 (-1.43%)

06:24
12/12/19
12/12
06:24
12/12/19
06:24
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADC

Agree Realty

$70.90

-1.34 (-1.85%)

06:23
12/12/19
12/12
06:23
12/12/19
06:23
Upgrade
Agree Realty rating change  »

Agree Realty upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$24.70

-0.17 (-0.68%)

06:22
12/12/19
12/12
06:22
12/12/19
06:22
Upgrade
VICI Properties rating change  »

VICI Properties upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$46.80

-0.95 (-1.99%)

06:21
12/12/19
12/12
06:21
12/12/19
06:21
Upgrade
UDR, Inc. rating change  »

UDR, Inc. upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DOC

Physicians Realty Trust

$18.64

-0.35 (-1.84%)

06:19
12/12/19
12/12
06:19
12/12/19
06:19
Upgrade
Physicians Realty Trust rating change  »

Physicians Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HR

Healthcare Realty Trust

$32.85

-0.59 (-1.76%)

06:18
12/12/19
12/12
06:18
12/12/19
06:18
Upgrade
Healthcare Realty Trust rating change  »

Healthcare Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,749.00

9.85 (0.57%)

06:18
12/12/19
12/12
06:18
12/12/19
06:18
Periodicals
Amazon sells children's smartwatches that are 'so easy to hack,' BI reports »

Amazon sells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$0.00

(0.00%)

06:16
12/12/19
12/12
06:16
12/12/19
06:16
Periodicals
SoftBank Vision Fund managing partner to leave company, Business Insider says »

Praveen Akkiraju, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$113.26

-0.32 (-0.28%)

06:15
12/12/19
12/12
06:15
12/12/19
06:15
Recommendations
Neurocrine analyst commentary  »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$85.16

-0.25 (-0.29%)

06:13
12/12/19
12/12
06:13
12/12/19
06:13
Hot Stocks
Exact Sciences announces new data supporting Oncotype DX Breast Recurrence Score »

Exact Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YETI

Yeti

$31.82

1.19 (3.89%)

06:12
12/12/19
12/12
06:12
12/12/19
06:12
Recommendations
Yeti analyst commentary  »

Piper highlights Yeti as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$35.23

0.13 (0.37%)

06:12
12/12/19
12/12
06:12
12/12/19
06:12
Hot Stocks
CEO of GM's Cruise unit hints at offering low-cost shared rides »

Dan Ammann, the former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

WST

West Pharmaceutical

$146.54

1.07 (0.74%)

06:11
12/12/19
12/12
06:11
12/12/19
06:11
Downgrade
West Pharmaceutical rating change  »

West Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$233.31

3.75 (1.63%)

06:09
12/12/19
12/12
06:09
12/12/19
06:09
Recommendations
Lululemon analyst commentary  »

Lululemon Q3 beat shows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$57.04

0.43 (0.76%)

, IBM

IBM

$133.81

-0.12 (-0.09%)

06:09
12/12/19
12/12
06:09
12/12/19
06:09
Periodicals
Intel hires former GlobalFoundries CTO Gary Patton, Reuters reports »

Intel (INTC) has hired…

INTC

Intel

$57.04

0.43 (0.76%)

IBM

IBM

$133.81

-0.12 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.